Associated Papers
Deficiency of adenosine deaminase 2 skews adaptive immune repertoires toward specific sets of T- and B-cell receptors.
Schultheiß C et al.
The Journal of Allergy and Clinical Immunology, 2025
[ADA2, an Adenosine Deaminase Isozyme Acting as a Regulator of Autoinflammation].
Ito M
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan, 2025
Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2.
Chen L et al.
The Journal of Allergy and Clinical Immunology, 2023
Systematic Review of Cerebral Phenotypes Associated With Monogenic Cerebral Small-Vessel Disease.
Whittaker E et al.
Journal of the American Heart Association, 2022
TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2).
Deuitch NT et al.
The Journal of Allergy and Clinical Immunology, 2022
Analysis of deficiency of adenosine deaminase 2 pathogenesis based on single-cell RNA sequencing of monocytes.
Watanabe N et al.
Journal of Leukocyte Biology, 2021
The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort.
Barron KS et al.
Frontiers in Immunology, 2021
35095905 (PubMed )
Supplement: Table_2.xlsx › Sheet1
Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.
Moens L et al.
Immunological Reviews, 2019
Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2.
Lee PY et al.
The Journal of Allergy and Clinical Immunology, 2018
Select a paper to view details